Skip to main content
search
Main navigation
Home
About
About ACSH
Financials
Our Team
Donate
Publications
Media/Contact
Subscribe
Write For Us
antiviral drug research
email
facebook
twitter
linkedin
pocket
reddit
print
China Claims an AIDS Drug Will Beat Covid. Too Good to Be True?
An article in The People's Daily Online, China's largest newspaper, reports that Azvudine (aka FNC), a reverse transcriptase inhibitor (1) – is be
Read more
Pfizer's COVID Pill Ought to Work. Here's Why. (And Some Good News About Merck's Molnupiravir)
As Professor Katherine Seley-Radtke (1) and I wrote last July in an op
Read more
Subscribe to antiviral drug research
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
NSAIDs: Pick Your Poison
We Need Reliable Science, Technology, and Medical Expertise in Trump 2.0
AI Runs Amok
Can You Be Fit And Fat?
Life Expectancy in Ten Americas: A Fragmented Melting Pot
ACSH Podcasts
Podcast: Have We Lost the Battle Against Cardiovascular Disease?
Podcast: Prohibition Unhinged: How Rigid Drug Laws Cost a Drug-Free Trucker His Job
Podcast: Should Scientists Deliberately Give People COVID?
Podcast: FDA Finally Listening to Reason on Opioids?
Podcast: Is Science Too Political? If So, What Do We Do About It?
More podcasts
Latest from Henry
The Media and I: Football and Brain Trauma
We Need Reliable Science, Technology, and Medical Expertise in Trump 2.0
The Media and I: Climate Change and Balloons
How Bureaucratic Infighting, Dairy Industry Lobbying Have Worsened H5N1 Bird Flu Outbreak (Part 2)
More articles
Latest from Josh
Potassium Iodide vs. Nuclear Radiation: What it Can, and Cannot, Do
Is the FDA Contributing to the Homelessness Crisis?
Methylene Blue: TikTok Craze, Plus a Dreaded Chemistry Lesson From Hell
12 Questions for RFK Jr.
More articles
Latest from Chuck
What I Am Reading November 28th
Can You Be Fit And Fat?
Sharing Without Caring, Using Social Media
Life Expectancy in Ten Americas: A Fragmented Melting Pot
More articles